Skip to Main content Skip to Navigation
Journal articles

Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine

Abstract : Shifting from the historical TNM paradigm to the determination of molecular and genetic subtypes of tumors has been a major improvement to better picture cancerous diseases. The sharper the picture is, the better will be the possibility to develop subsequent strategies, thus achieving higher efficacy and prolonged survival eventually. Recent studies suggest that urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), and plasmino-gen activator inhibitor-1 (PAI-1) may play a critical role in cancer invasion and metastasis. Consistent with their role in cancer dissemination, high levels of uPA, PAI-1, and uPAR in multiple cancer types correlate with dismal prognosis. In this respect, upfront determination of uPA and PAI-1 as invasion markers has further opened up the possibilities for individualized therapy of breast cancer. Indeed, uPA and PAI-1 could help to classify patients on their risk for metastatic spreading and subsequent relapse, thus helping clinicians in their decision-making process to propose, or not propose, adjuvant therapy. This review covers the implications for cancer diagnosis, prognosis, and therapy of uPA and PAI-1, and therefore how they could be major actors in the development of a precision medicine in breast cancer.
Document type :
Journal articles
Complete list of metadatas

Cited literature [77 references]  Display  Hide  Download

https://hal-amu.archives-ouvertes.fr/hal-01478883
Contributor : Joseph Ciccolini <>
Submitted on : Tuesday, February 28, 2017 - 2:33:03 PM
Last modification on : Friday, October 23, 2020 - 4:46:00 PM
Long-term archiving on: : Monday, May 29, 2017 - 2:33:53 PM

File

bmi-11-2016-105.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Adel Gouri, Aoulia Dekaken, Khalid El Bairi, Arifa Aissaoui, Nihad Laabed, et al.. Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine. Biomarker Insights, 2016, 11, pp.105-111. ⟨10.4137/Bmi.s33372⟩. ⟨hal-01478883⟩

Share

Metrics

Record views

214

Files downloads

379